Technology

August 30, 2010 - The U.S. Food and Drug Administration (FDA) granted clearance for SonoSite’s LumenVu Catheter Guidance System....

Ablavar is a contrast agent approved for use with a magnetic resonance angiography (MRA) indication to evaluate aortoiliac occlusive disease (AIOD) and suspected peripheral vascular disease.

...

HemCon Medical Technologies offers a more flexible HemCon Patch designed for use for external, temporary control of bleeding during interventional and diagnostic cardiac catheterization, interventiona...

The first interwoven nitinol self-expanding stent available in the U.S. for palliative treatment of malignant strictures in the biliary tree, the SureSave Stent will be renamed SUPERA....